Evaluation of the Possibility to Detect Circulating Tumor DNA From Pituitary Adenoma

Objective: Circulating free DNA (cfDNA) in general and circulating tumor DNA (ctDNA) in particular is becoming an increasingly used form of liquid biopsy biomarkers. In this study, we are investigating the ability to detect ctDNA from the plasma of pituitary adenoma (PA) patients. Design: Tumor tiss...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Endocrinol (Lausanne)
Autors principals: Megnis, Kaspars, Peculis, Raitis, Rovite, Vita, Laksa, Pola, Niedra, Helvijs, Balcere, Inga, Caune, Olivija, Breiksa, Austra, Nazarovs, Jurijs, Stukens, Janis, Konrade, Ilze, Pirags, Valdis, Klovins, Janis
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2019
Matèries:
Endocrinology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6759656/
https://ncbi.nlm.nih.gov/pubmed/31620080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2019.00615
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars